• +1 (732) 369 9777
  • +1 (732) 629 9444
  • enquiry@dimensionmarketresearch.com
logo Synthetic Biology Market

Comprehensive Industry Landscape and Strategic Outlook

  • About Us
  • Insight
    Trending Reports Latest Reports
  • Industries
    Aerospace & Defence
    Agriculture & Horticulture
    Automotive
    BFSI & Education
    Chemical & Material
    Consumer Goods
    Electrical & Semiconductor
    ICT & TMT
    Energy & Power
    Food & Beverages
    Industry Automation & Equipment
    Manufacturing & Construction
    Medical Devices & Healthcare IT
    Metals & Minerals
    Packaging & Logistics
    Pharmaceuticals & Healthcare
    Sports & Fitness
  • News And Media
  • Contact us
Speak to Analyst
Request Free Sample
/images/logo.png
  • home
  • Medical Devices & Healthcare IT
  • Synthetic Biology Market

Synthetic Biology Market By Product (Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, and Others), By Technology, By Application - Global Industry Outlook, Key Companies (Thermo Fisher Scientific, Inc., Merck KGaA, Novozymes, and others), Trends and Forecast 2023-2032

Published on : November-2023  Report Code : RC-750  Pages Count : 248  Report Format : PDF
Overview Table of Content Download Report's Excerpt Request Free Sample

Market Overview

The Global Synthetic Biology Market is projected to reach a value of USD 16.6 billion in 2023 & USD 89.9 billion in 2032 with the anticipated CAGR of 20.6% during the forecast period (2023-2032).

Synthetic Biology Market Growth Analysis

Synthetic biology integrates various disciplines such as biophysics, molecular biology, biotechnology, and genetic engineering. This interdisciplinary approach is critical in the development of biopharmaceuticals, biomaterials, and bio-plasticizers.

Two prevalent approaches used in synthetic biology are the bottom-up and top-down techniques. The top-down approach involves modifying and developing existing biological systems to create synthetic products that find applications in sectors such as healthcare, pharmaceuticals, biorefinery, agriculture, biotechnology, and more.

Market expansion is expected to be driven by the growing need for personalized healthcare solutions, protein therapies, and innovations in artificial vaccines and drugs.

In addition, advancements in cell and gene therapy, stem cell therapy, regenerative medicine, and precision medicine are expected to accelerate the adoption of synthetic biology technologies. Reduced costs in synthesis and DNA sequencing are further anticipated to propel the market.

Throughout the forecast period, the synthetic biology industry’s growth is projected to gain momentum because of factors such as widened applications of artificial biology, increased spending on synthetic biology, R&D expenditures, and significant government and private sector support.

Key Takeaways

  • The Global Synthetic Biology Market is projected to reach USD 16.6 billion in 2023 and USD 89.9 billion in 2032, with a CAGR of 20.6%.
  • Oligonucleotides and synthetic DNA dominate the market, holding the largest share in 2023.
  • Polymerase Chain Reaction (PCR) technology leads the market under the technology segment in terms of revenue.
  • The healthcare segment holds the largest revenue share in 2023, driven by advancements in disease detection and treatment.
  • North America leads the market with a 43.2% revenue share in 2023, supported by government regulations and private spending.

Market Dynamic

The Global Synthetic Biology Market is expected to experience growth owing to heightened R&D efforts across various sectors, including biotechnology, generative AI in biology, and biopharmaceutical applications.

Companies are leveraging synthetic biology techniques to improve efficiency, optimize resource usage, and enhance the production of biofuels through microbial fermentation technology. Fashion companies like Modern Meadow, Bolt Threads, and Vitro Labs are utilizing biotechnological methods to create eco-friendly materials using synthetic biology.

Other factors influencing market growth include amplified government and private sector support for R&D in bioprocessing and biomanufacturing. Additionally, collaborations and partnerships are driving further development, especially in the areas of biorefinery and microbial fermentation technology.

However, the key biosafety concern in synthetic biology involves the accidental or intentional release of engineered organisms into the environment. These engineered organisms, if released, may mutate or interact with native species, causing unintended consequences for wildlife and natural habitats. Furthermore, the development of antibiotic-resistant bacteria poses a substantial threat to biosecurity.

Research Scope and Analysis

By Product

The product is categorized under six headings, i.e., Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, Chassis Organism, and Synthetic Cells.

Among these, Oligonucleotides and synthetic DNA dominate the segment, commanding the maximum share in 2023. Oligonucleotides and synthetic DNA form the basic components in the domain of molecular biology. 

These sectors are involved in major applications related to gene sequencing and gene editing, including CRISPR Cas technology, and several other techniques involved in treatment & drug discoveries. Enhanced acceptance of DNA Computing & NGS technologies, propelling the market growth.
 
For example, OligoMix revolutionizes genomics research with its specific & personalized solution. Enabling the synthesis of a wide range of oligonucleotide sequences in parallel, it allows researchers to make advanced discoveries in the field of genomics.

Furthermore, the enzymes domain is projected to experience the fastest growth. As these enzymes are utilized in biological reactions to catalyze the reaction to enhance the speed & specific product formation.

By Technology

Under the technology segmentation, it is further categorized into Polymerase Chain Reaction (PCR) Technology, Next Generation Sequencing (NSG) Technology, Genome Editing Technology, Bioprocessing Technology, and Others. Among these, the Polymerase Chain Reaction (PCR) sector leads the market with the maximum share in 2023, in terms of revenue. 

Synthetic Biology Market Technology Analysis
 
This sector’s growth can be attributed to the enhanced growth in the sequencing & detection domain. In order to get the particular gene sequence & to create multiple copies in a short span of time, PCR dominates the segment and is also anticipated to grow further in the near future.
 
Several types of PCR such as real-time, qPCR, RT-PCR, etc. have gained momentum in the recent past with an elevated increase, especially in RT-PCR due to the recent pandemic has further led this segment to foster the growth of the market during the forecast period (2023-2032).

Moreover, gene editing technology is further anticipated to grow rapidly in the forthcoming years due to the increased desire for genetically modified products, whether it is genetically modified plants or genetically modified species. In order to cater to the needs of particular & specific traits, such technologies have led the advancements in healthcare, and various other sectors.

By Applications

Under the segmentation of application, the healthcare segment stands at the top, holding a major share of the total revenue in 2023. This dominance is due to the enhanced awareness regarding early detection of diseases & effective treatments. Diagnosis labs, growth and surge in increased usage of hospitals have led to the developments in this sector. 
 
Increasing disorders related to neurology, and other infectious diseases such as HIV, have surged the advanced developments in the healthcare sector. With the changed lifestyle and increased cases of mutations in genes, several techniques & therapeutics regarding early-stage diseases, such as cancer cell detections, etc. have developed which further propel this market’s growth.

Moreover, researchers around the world are engaged in research activities for further advancements & better drug delivery systems. Healthcare is the major sector that is in prime focus and hence such advancements are crucial wherein Synthetic Biology plays an important sector.

The Global Synthetic Biology Market Report is segmented based on the following:

By Product

  • Oligonucleotide/Oligo Pools and Synthetic DNA
  • Enzymes
  • Cloning Technologies Kits
  • Xeno-Nucleic Acids
  • Chassis Organism
  • Synthetic Cells

By Technology

  • Polymerase Chain Reaction (PCR) Technology
  • Next Generation Sequencing (NSG) Technology
  • Genome Editing Technology
  • Bioprocessing Technology
  • Others

By Application

  • Healthcare
    • Clinical
    • Non-Clinical
  • Non-healthcare
    • Industrial
    • Food & Agriculture
    • Environmental

Regional Analysis

The region of North America leads the market with 43.2% of the total revenue share in 2023. This prominence can be attributed to the government’s supportive and encouraging rules & regulations with stringent policies, and the enhanced spending in private entities.

The elevated research & development propelled this market in this region, especially in the field of drug discovery & drug screening, genome sequencing, proteomics, etc. The synthetic biologics market has gained momentum in recent years with the increasing concerns regarding health & food & security.

 
Synthetic Biology Market Regional Analysis
 
Moreover, the region of Asia-Pacific is projected to be the fastest-growing one. This growth can be attributed to the growing investments in such a nation, with the increased FDI & huge spending shares in Research & development.
 
The enhanced concerns regarding the production of drugs for several diseases & ill health have resulted in the development of laboratories and incubation centers. To cater to the requirements of research developments have resulted in establishing research centers, national institutions, etc. Enhanced collaborations & partnerships are one of the factors behind the growth of this market in the Asia-Pacific region.

By Region

North America
  • The U.S.
  • Canada
Europe
  • Germany
  • The U.K.
  • France
  • Italy
  • Russia
  • Spain
  • Benelux
  • Nordic
  • Rest of Europe
Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • ANZ
  • ASEAN
  • Rest of Asia-Pacific
Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America
Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Israel
  • Egypt
  • Rest of MEA

Competitive Landscape

Prominent industry participants are employing diverse tactics to enhance their profitability, such as forming partnerships, expanding into new geographical regions, executing mergers & acquisitions, and engaging in strategic collaborations. For example, Codexis, Inc. and Kalsec, Inc. disclosed the extension of their joint research efforts & entered into an exclusive supply arrangement for a novel enzyme, intended for the production of Kalsec’s latest natural hop acid, in July 2021.

Some of the prominent players in the Global Synthetic Biology Market are:
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Novozymes
  • Agilent Technologies, Inc.
  • Creative Enzymes
  • Creative Biogene
  • Codexis, Inc.
  • Bota Biosciences Inc.
  • Eurofins Scientific
  • Pareto Bio, Inc.
  • New England Biolabs
  • Other Key Players

Recent Developments

  • In June 2025, a $12 million grant supports a global team working on creating the first synthetic plant chromosome. The project aims to revolutionize plant biology through synthetic biology advancements.
  • In June 2025, Antheia raised $56 million in Series C funding to address global drug shortages using synthetic biology. The company plans to scale its technology for sustainable drug production.
  • In March 2025, Seattle's Synthetic Biology Hub secured $10 million to support the development of "DNA Typewriter" technology. The funding will help accelerate innovations in gene synthesis and DNA programming.

Report Details

                             Report Characteristics
Market Size (2023) USD 16.6 Bn
Forecast Value (2032) USD 89.9 Bn
CAGR (2023-2032) 20.6%
Historical Data 2017 - 2022
Forecast Data 2023 - 2032
Base Year 2022
Estimate Year 2023
Report Coverage Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc.
Segments Covered By Product (Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, Chassis Organism, and Synthetic Cells), By Technology (Polymerase Chain Reaction (PCR) Technology, Next Generation Sequencing (NSG) Technology, Genome Editing Technology, Bioprocessing Technology, and Others), and By Application (Healthcare, and Non-healthcare).
Regional Coverage North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
Prominent Players Thermo Fisher Scientific, Inc., Merck KGaA, Novozymes, Agilent Technologies, Inc., Creative Enzymes, Creative Biogene, Codexis, Inc., Bota Biosciences Inc., Eurofins Scientific, Pareto Bio, Inc., New England Biolabs, and Other Key Players.
Purchase Options We have three licenses to opt for: Single User License (Limited to 1 user), Multi-User License (Up to 5 Users), and Corporate Use License (Unlimited User) along with free report customization equivalent to 0 analyst working days, 3 analysts working days and 5 analysts working days respectively.
 

 

Frequently Asked Questions

  • How big is the Global Smart Inhaler Technology Market?

    The Global Smart Inhaler Technology Market size is estimated to have a value of USD 1.3 billion in 2023 and is expected to reach USD 3.5 billion by the end of 2032.

  • Which region accounted for the largest Global Smart Inhaler Technology Market?

    North America has the largest market share for the Global Smart Inhaler Technology Market with a share of about 39.9% in 2023.

  • Who are the key players in the Global Smart Inhaler Technology Market?

    Some of the major key players in the Global Smart Inhaler Technology Market are 3M Healthcare, Novartis, FindAir, and many others.

  • What is the growth rate in the Global Smart Inhaler Technology Market?

    The market is growing at a CAGR of 11.3 percent over the forecasted period.

  • Contents

      1.Introduction
        1.1.Objectives of the Study
        1.2.Market Scope
        1.3.Market Definition and Scope
      2.Synthetic Biology Market Market Overview
        2.1.Global Synthetic Biology Market Market Overview by Type
        2.2.Global Synthetic Biology Market Market Overview by Application
      3.Synthetic Biology Market Market Dynamics, Opportunity, Regulations, and Trends Analysis
        3.1.Market Dynamics
          3.1.1.Synthetic Biology Market Market Drivers
          3.1.2.Synthetic Biology Market Market Opportunities
          3.1.3.Synthetic Biology Market Market Restraints
          3.1.4.Synthetic Biology Market Market Challenges
        3.2.Emerging Trend/Technology
        3.3.PESTLE Analysis
        3.4.PORTER'S Five Forces Analysis
        3.5.Technology Roadmap
        3.6.Opportunity Map Analysis
        3.7.Case Studies
        3.8.Opportunity Orbits
        3.9.Pricing Analysis
        3.10.Ecosystem Analysis
        3.11.Supply/Value Chain Analysis
        3.12.Covid-19 & Recession Impact Analysis
        3.13.Product/Brand Comparison
      4.Global Synthetic Biology Market Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Product, 2017-2032
        4.1.Global Synthetic Biology Market Market Analysis by Product: Introduction
        4.2.Market Size and Forecast by Region
        4.3.Oligonucleotide/Oligo Pools and Synthetic DNA
        4.4.Enzymes
        4.5.Cloning Technologies Kits
        4.6.Xeno-Nucleic Acids
        4.7.Chassis Organism
        4.8.Synthetic Cells
      5.Global Synthetic Biology Market Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Technology, 2017-2032
        5.1.Global Synthetic Biology Market Market Analysis by Technology: Introduction
        5.2.Market Size and Forecast by Region
        5.3.Polymerase Chain Reaction (PCR) Technology
        5.4.Next Generation Sequencing (NSG) Technology
        5.5.Genome Editing Technology
        5.6.Bioprocessing Technology
        5.7.Others
      6.Global Synthetic Biology Market Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2017-2032
        6.1.Global Synthetic Biology Market Market Analysis by Application: Introduction
        6.2.Market Size and Forecast by Region
        6.3.Healthcare
        6.4.Non-healthcare
      10.Global Synthetic Biology Market Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2017-2032
        10.1.North America
          10.1.1.North America Synthetic Biology Market Market: Regional Analysis, 2017-2032
            10.1.1.1.The US
            10.1.1.2.Canada
        10.2.1.Europe
          10.2.1.Europe Synthetic Biology Market Market: Regional Trend Analysis
            10.2.1.1.Germany
            10.2.1.2.France
            10.2.1.3.UK
            10.2.1.4.Russia
            10.2.1.5.Italy
            10.2.1.6.Spain
            10.2.1.7.Nordic
            10.2.1.8.Benelux
            10.2.1.9.Rest of Europe
        10.3.Asia-Pacific
          10.3.1.Asia-Pacific Synthetic Biology Market Market: Regional Analysis, 2017-2032
            10.3.1.1.China
            10.3.1.2.Japan
            10.3.1.3.South Korea
            10.3.1.4.India
            10.3.1.5.ANZ
            10.3.1.6.ASEAN
            10.3.1.7.Rest of Asia-Pacifc
        10.4.Latin America
          10.4.1.Latin America Synthetic Biology Market Market: Regional Analysis, 2017-2032
            10.4.1.1.Brazil
            10.4.1.2.Mexico
            10.4.1.3.Argentina
            10.4.1.4.Colombia
            10.4.1.5.Rest of Latin America
        10.5.Middle East and Africa
          10.5.1.Middle East and Africa Synthetic Biology Market Market: Regional Analysis, 2017-2032
            10.5.1.1.Saudi Arabia
            10.5.1.2.UAE
            10.5.1.3.South Africa
            10.5.1.4.Israel
            10.5.1.5.Egypt
            10.5.1.6.Turkey
            10.5.1.7.Rest of MEA
      11.Global Synthetic Biology Market Market Company Evaluation Matrix, Competitive Landscape, Market Share Analysis, and Company Profiles
        11.1.Market Share Analysis
        11.2.Company Profiles
        11.3.Thermo Fisher Scientific, Inc.
          11.3.1.Company Overview
          11.3.2.Financial Highlights
          11.3.3.Product Portfolio
          11.3.4.SWOT Analysis
          11.3.5.Key Strategies and Developments
        11.4.Merck KGaA
          11.4.1.Company Overview
          11.4.2.Financial Highlights
          11.4.3.Product Portfolio
          11.4.4.SWOT Analysis
          11.4.5.Key Strategies and Developments
        11.5.Novozymes
          11.5.1.Company Overview
          11.5.2.Financial Highlights
          11.5.3.Product Portfolio
          11.5.4.SWOT Analysis
          11.5.5.Key Strategies and Developments
        11.6.Agilent Technologies, Inc.
          11.6.1.Company Overview
          11.6.2.Financial Highlights
          11.6.3.Product Portfolio
          11.6.4.SWOT Analysis
          11.6.5.Key Strategies and Developments
        11.7.Creative Enzymes
          11.7.1.Company Overview
          11.7.2.Financial Highlights
          11.7.3.Product Portfolio
          11.7.4.SWOT Analysis
          11.7.5.Key Strategies and Developments
        11.8.Creative Biogene
          11.8.1.Company Overview
          11.8.2.Financial Highlights
          11.8.3.Product Portfolio
          11.8.4.SWOT Analysis
          11.8.5.Key Strategies and Developments
        11.9.Codexis, Inc.
          11.9.1.Company Overview
          11.9.2.Financial Highlights
          11.9.3.Product Portfolio
          11.9.4.SWOT Analysis
          11.9.5.Key Strategies and Developments
        11.10.Bota Biosciences Inc.
          11.10.1.Company Overview
          11.10.2.Financial Highlights
          11.10.3.Product Portfolio
          11.10.4.SWOT Analysis
          11.10.5.Key Strategies and Developments
        11.11.Eurofins Scientific
          11.11.1.Company Overview
          11.11.2.Financial Highlights
          11.11.3.Product Portfolio
          11.11.4.SWOT Analysis
          11.11.5.Key Strategies and Developments
        11.12.Pareto Bio, Inc.
          11.12.1.Company Overview
          11.12.2.Financial Highlights
          11.12.3.Product Portfolio
          11.12.4.SWOT Analysis
          11.12.5.Key Strategies and Developments
        11.13.New England Biolabs
          11.13.1.Company Overview
          11.13.2.Financial Highlights
          11.13.3.Product Portfolio
          11.13.4.SWOT Analysis
          11.13.5.Key Strategies and Developments
        11.14.Other Key Players
          11.14.1.Company Overview
          11.14.2.Financial Highlights
          11.14.3.Product Portfolio
          11.14.4.SWOT Analysis
          11.14.5.Key Strategies and Developments
      12.Assumptions and Acronyms
      13.Research Methodology
      14.Contact
    If your country is missing in the list, we apologize that we still do not serve in your country.

    ✅ 100% Privacy – Your Information is Safe
    ✅ Secure & Encrypted Form Submission
    If your country is missing in the list, we apologize that we still do not serve in your country.

    ✅ 100% Privacy – Your Information is Safe
    ✅ Secure & Encrypted Form Submission

    Select License Type

    Special Offer
    • License
    • Report Price :$
    • TOTAL$
    • Single User License $ 3190 $ 3030(5% off)
    • Multi-User License $ 4590 $ 4131(10% off)
    • Corporate License $ 5690 $ 4836(15% off)
    • Data Set (Excel) $ $ 1320(5% off)

    • RC-750

    • November-2023
      • ★★★★★
        ★★★★★
      • 47
    Buy Now

    Customization Request

    Quick Contact

    • Chat on Whatsapp
    • USA Flag
      +1 732 369 9777
    • India Flag
      +91 882 677 4855
    • Contact By Email
    Clients We Serve
    Market Research Report Cover

    Recent Report

    • Metaverse in Healthcare Market
    • Hyperspectral Imaging Market
    • Electronic Health Records Market
    • Digital Diabetes Management Market
    • Medical Aesthetics Market
    • Sports Nutrition Market
    • Healthcare Cybersecurity Market
    • Laparoscopy and Endoscopy Devices Market
    • Medical Foam Market
    • Blood Micro-Sampling Medical Devices Market
    Secured Payment Options
      /images/payment.png
    Legal
    • Privacy Policy
    • Refund Policy
    • Frequently Asked Questions
    • Terms and Conditions
    Explore Company
    • About Us
    • Contact Us
    • Trending Reports
    • Latest Reports
    • All Industries
    • How to Order
    Contact Detail
    • 957 Route 33, Suite 12 #308
            Hamilton Square, NJ-08690 USA
    • +1 (123) 456 4562 (International)
    • +1 (732) 629 9444 (International)
    • +91 882 677 4855 (Asia)
    • sales@dimensionmarketresearch.com
    Copyright Dimension Market Research. ©2025 All rights reserved